Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Pregabalin 150 mg hard capsules versus Lyrica in healthy Thai volunteers under fasting conditions
TCTR20211229002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin (2 arms), sponsored by Bio-innova. Planned start May 2022; status: not yet recruiting.
02
Drugs
pregabalin
Beyond the preview
Go deeper on TCTR20211229002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211229002.